Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TM, Powell EE, Roden M, Romero-Gmez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW-S, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN, NAFLD Nomenclature consensus group (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature
UM: Writing review & editing
Jada always has a listening ear and an encouraging word and for that I am grateful.Denise ReneeAlways a pleasure doing business with Dr Jada the REAL MD
In situ gel: new trends in controlled and sustained drug delivery system
[Google Scholar] Bijalwan S, Randhawa GK, Kaur T: A prospective, randomized and open label study to compare efficacy, safety and quality of life impact of topical glutathione (2%) in comparison to topical tranexamic acid (3%) in adult melasma patients
Raun 1998 (Ipamorelin) demostr en modelos animales que Ipamorelin libera GH sin elevar ACTH/cortisol ni prolactina a dosis equipotentes
